Contexte :

Cancer metabolism is one of the oldest areas of research in cancer biology, predating the discovery of oncogenes and tumor suppressors by some 50 years. The field is based on the principle that metabolic activities are altered in cancer cells relative to normal cells, and that these alterations support the acquisition and maintenance of malignant properties. Because some altered metabolic features are observed quite generally across many cancer types, reprogrammed metabolism is considered a hallmark of cancer. The key questions driving research in the field should be devoted to identifying key metabolic candidates whose inactivation might severely impair tumor cells while sparing normal cells for therapeutic benefits. Unfortunately, the high metabolic adaptability of tumor cells to find alternative pathways frequently frustrates recent therapeutic interventions.

We thus need to explore in some detail the possibilities for cancerous cells to grow, and determine if cancer cells are able to multiply using the resources available in their micro environment, in the presence or absence of specific therapeutic agents. To address this problem, an approach is to use whole-cell modeling to account not only for metabolic activities, but also for other cellular functions that can be impacted during cancer cells adaptation. Among whole-cell modeling techniques, the constraint-based modeling (CBM) framework, and especially, the resource balance analysis (RBA) framework (developed in MaIAGE) is particularly promising to tackle this challenge since it offers a good trade-off between prediction accuracy of cell phenotypes and numerical tractability.

Missions :

We propose to develop a novel and comprehensive CBM analysis using the RBA methods to predict the ability of cancer cells to grow and develop computational tools for defining therapeutic strategies. We will integrate datasets and relevant biological constraints from Cochin’s lab in order to identify only the subset of application-specific, biologically relevant pathways. Thus, the scientific objectives are summarized as follows:

1. Develop genome scale models, according to biological tissues handled and to specificities of the metabolic network studied;

2. Extensively validate, test and compare the models developed above for cancer cell metabolism using available and newly generated omics datasets;

3. Extend the Resource Balance Analysis framework to eukaryotic cells to compare cancer and non-tumoral cells, predict essential processes of the cancer cell to growth predict the alternative pathway and propose therapeutic strategies to kill the cancer cells.

Compétences :

We are looking for candidates with a phD in bioinformatics or systems biology. Candidates having a phD in biology will be considered if they justify of a significant experience in bioinformatics/systems biology. An experience in constraint-based modeling is encouraged. Knowledge on cellular biology/metabolism. Knowledge on logic programming would be a plus. Capabilities of being autonomous. Capabilities (and appetite) for interdisciplinary works. Programming language: Python (mandatory), Matlab (optional, but recommended). The R language can sometimes be used.